Appeal No. 1997-1826
Application No. 08/304,951
remaining claims in this application, were amended subsequent
to the final rejection and have been allowed by the examiner
(see the amendment dated Aug. 21, 1995, Paper No. 8; the
Advisory Action dated Sept. 11, 1995, Paper No. 9; and the
Brief, page 2).
According to appellants, the invention is directed to
intermediates of a specified formula useful in the synthesis
of certain tetrahydroimidazo[1,4]benzodiazepin-2-(thi)ones
that have anti-retroviral properties (Brief, pages 2-3).
Appellants state that the appealed claims stand or fall
together (Brief, page 3). In accordance with this statement
and the provisions of 37 CFR
§ 1.192(c)(7)(1995), we select claim 14 from the group of
claims and decide this appeal as to the ground of rejection on
the basis of this claim alone. A copy of illustrative claim
14 is reproduced and attached as an Appendix to this decision.
The examiner has relied upon the following reference as
evidence of obviousness:
Carabateas 3,384,635 May 21, 1968
2
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next
Last modified: November 3, 2007